Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ciba Vision sales up 4% in first half:

This article was originally published in Clinica

Executive Summary

Ciba Vision benefited from strong demand for high volume lenses in optics as well as a vigorous advance in ophthalmic pharmaceutical sales. The ophthalmic division of Swiss pharmaceutical company Ciba saw sales increase 4% to SwFr 551 million ($467 million) in the first half of 1995 while Ciba's total healthcare sales fell 9% to SwFr 3,873 million. The decline was largely due to the transfer of Ciba's diagnostics business to US-based Chiron.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093067

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel